Disease Markers

Disease Markers / 2013 / Article

Open Access

Volume 34 |Article ID 871929 | https://doi.org/10.3233/DMA-120947

Imen Ferchichi, Samia Sassi Hannachi, Amal Baccar, Raja Marrakchi Triki, Jean Yves Cremet, Khaled Ben Romdhane, Claude Prigent, Amel Ben Ammar El Gaaied, "Assessment of Aurora a Kinase Expression in Breast Cancer: A Tool for Early Diagnosis?", Disease Markers, vol. 34, Article ID 871929, 7 pages, 2013. https://doi.org/10.3233/DMA-120947

Assessment of Aurora a Kinase Expression in Breast Cancer: A Tool for Early Diagnosis?

Received24 Dec 2012
Accepted24 Dec 2012

Abstract

Aurora A kinase is overexpressed in many cancers but the status of this protein in the breast cancer often varies. We investigate the expression and localization of Aurora A protein in relation with tumor emergence and progression in breast cancer. Aurora A kinase status was evaluated in 107 patients using immunohistochemistry. The experimental findings showed that high expression of the Aurora A protein was correlated with elevated nuclear grade, low expression of progesterone receptor and positive nodal status. The experimental results showed also that the localization of this kinase shifts from cytoplasm in non malignant adjacent tissue to both cytoplasmic and nuclear compartments in tumoral tissue, suggesting an oncogenic role of the nuclear accumulation. We have, furthermore, detected the overexpression of this protein in non malignant adjacent tissue. The expression of the Aurora A kinase in non malignant tissue may represent an earlier diagnosis tool for breast cancer.

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views602
Downloads682
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.